Beyond Basic Beta Content Hub For Long-Term Value Fans, Early Investments May Be Paying Off By Tom LydonJune 9, 2021
Innovative ETFs Content Hub Will Biotech ETFs Benefit from Biogen’s New Alzheimer’s Drug? By Ian YoungJune 9, 2021
Beyond Basic Beta Content Hub As COVID Recedes, Gambling Stocks Wagering on a Comeback By Tom LydonJune 7, 2021
Beyond Basic Beta Content Hub Why Vietnam Could Be a Victorious Idea for Investors By Tom LydonJune 7, 2021
ETF Building Blocks Content Hub Midstream Dividend ETFs Are Showing Their Mettle By Tom LydonJune 4, 2021
Beyond Basic Beta Content Hub Stock Selection Making ‘MOAT’ a Magnificent Value Alternative By Tom LydonJune 3, 2021
Beyond Basic Beta Content Hub Some Junk Bonds Still Offer Big Yields. Knowing Where to Look Is Key By Tom LydonJune 3, 2021
Beyond Basic Beta Content Hub Artificial Intelligence Set to Transform the Pharmaceutical Industry By Ben HernandezJune 1, 2021
Beyond Basic Beta Content Hub Why Seek Out ‘Moats’ in Your Value Investing Strategy? By Ben HernandezJune 1, 2021
Beyond Basic Beta Content Hub Trends with Benefits #54—REVISITED: Advisor Trends with Tom Lydon and Dave Nadig By VanEckJune 1, 2021
ETF Building Blocks Content Hub The Winds of Change Are Blowing in the Midstream Energy Space By Tom LydonMay 27, 2021
Beyond Basic Beta Content Hub The Iran Nuclear Deal Is Moving Key Oil ETFs By Ben HernandezMay 27, 2021
